CERVICOGRAPHY - ADJUNCTIVE CERVICAL-CANCER SCREENING BY PRIMARY-CARE CLINICIAN

Citation
Dg. Ferris et al., CERVICOGRAPHY - ADJUNCTIVE CERVICAL-CANCER SCREENING BY PRIMARY-CARE CLINICIAN, Journal of family practice, 37(2), 1993, pp. 158-164
Citations number
27
Categorie Soggetti
Medicine, General & Internal
Journal title
ISSN journal
00943509
Volume
37
Issue
2
Year of publication
1993
Pages
158 - 164
Database
ISI
SICI code
0094-3509(1993)37:2<158:C-ACSB>2.0.ZU;2-2
Abstract
Background. Cervicography is an adjunct method of cervical cancer scre ening intended to complement cervical cytologic sampling, ie, Papanico laou (Pap) smear. Cervicography involves obtaining and evaluating a ph otographic image of the cervix. The purpose of this investigation was to evaluate the screening use of cervicography as an adjunct to clinic al cytologic screening. Methods. Women presenting at four clinical sit es for annual cervical cytologic screening or for follow-up evaluation after receiving an abnormal Pap smear result were enrolled in the stu dy. Each patient received a Pap smear and a cervigram. Those women in whom abnormalities were detected by either test subsequently underwent colposcopy, and when appropriate, histologic specimens were obtained. Results. Pap smear and cervigram data were obtained for 1449 women. W hen premalignant or malignant histologic test results were considered as a true positive, the Pap smear correctly identified 25.6% of subjec ts with dysplasia and 37.5% with severe dysplasia. The Pap smear faile d to identify the one patient with invasive cancer. The cervigram dete cted 50.5% of the subjects with dysplasia and 77.8% of the subjects wi th severe dysplasia, and it identified the one patient with invasive c ancer when a positive cervigram was considered a true positive. When t he results were combined, the two tests identified 62.9% of subjects w ith histologically confirmed dysplasia, 81.3% of subjects with severe dysplasia, and 100% (one patient) with cancer. Conclusions. The cervig ram detected twice the number of patients with premalignant disease as the Pap smear alone, and correctly identified the invasive cancer. Ce rvicography improved the detection of cervical